LAS VEGAS, Aug. 24, 2017 (GLOBE NEWSWIRE) -- THC Therapeutics (OTC: THCT) is in the process of completing an audit which will allow us to be fully reporting to the Securities and Exchange Commission. We have hired AMC Auditing in Las Vegas, NV to complete our audit. We expect the audit to be completed in the next 60 days. To facilitate this, we’ve hired Blue Chip Accounting in Henderson, NV to be our new CPA. We’ve also hired Steve Bean from Legends Law Group out of Kaysville, UT as our Patent Attorney for the dHydronator® and other intellectual property. In addition to the previously mentioned firms, THC Therapeutics has also hired a new Securities Attorney out of Salt Lake City, UT.
The dHydronator® is a sanitizing herb dryer capable of reducing the drying time of cannabis from 10-14 days down to less than 14 hours. With our built-in, optional SanitiZen® technology we are able to reduce the microbial load from failing cannabis and bring the contaminants down to passing levels while maintaining the integrity of the plant. This device has been rigorously tested by two 3rd party independent laboratories. Over the 9 tests and 6 strains tested on the 2nd generation prototype, we have seen a 4% average increase of THC-A. This increase in THC-A has never before been seen during the drying process. Links to testing reports –
1st Generation testing (http://thctherapeutics.com/wp-content/uploads/2017/03/CannLabs-Report.pdf)
2nd Generation testing (http://thctherapeutics.com/wp-content/uploads/2017/06/Censored-Lab-Report-DigiPath.pdf)
Please read our research report from Equities.com - https://www.equities.com/news/thc-therapeutics-thct-unlocking-the-health-and-wellness-potential-of-cannabis
A press release is coming out in the next few weeks to update everyone on the dHydronator® and the health and wellness spa.
Comments from our Founder & CEO Brandon Romanek: “One of our first goals since we went public was to become a fully reporting company as quickly as possible. By becoming fully reporting, we are increasing our transparency to the next level, showing the investment community our commitment to doing things the right way. Becoming fully reporting will allow us to raise capital on better terms and attract more sophisticated investors. Offers have been made for THCT to raise capital that would have had a negative impact on our shareholders, but every one of these offers were rejected. I’ve made it very clear one of the big ways to grow THC Therapeutics is by mergers, acquisitions and partnerships, for this to happen we need to be fully reporting. We are currently in discussions with several companies in the healthcare and cannabis industries.”
About THC Therapeutics:
THC Therapeutics is a forward-thinking publicly traded health and healing company in the cannabis industry that has “Better Health through the Science of Nature” as their mission statement. The company is dedicated to innovating new methods and refining current industry standards in the cannabis market. We are currently in product development on the dHydronator® and a subsequent product line to follow up after the dHydronator's® release. The dHydronator® is a sanitizing herb dryer capable of reducing the drying time of cannabis from 10-14 days down to less than 14 hours. With our built-in, optional SanitiZen® technology we are able to reduce the microbial load from failing cannabis and bring the contaminants down to passing levels while maintaining the integrity of the plant. THC Therapeutics plans for future growth include cannabis technology products, personal wellness centers and flotation therapy. For more information, visit THCTherapeutics.com.
Forward-Looking Statements Disclosure:
This press release may contain “forward-looking statements” within the meaning of the federal securities laws. In this context, forward-looking statements may address the Company’s expected future business and financial performance, and often contain words such as “anticipates,” “beliefs,” “estimates,” “expects,” “intends,” ”plans,” “seeks,” “will,” and other terms with similar meaning. These forward-looking statements by their nature address matters that are, to different degrees, uncertain. Although the Company believes that the assumptions upon which its forward-looking statements based are reasonable, it can provide no assurances that these assumptions will prove to be correct. All forward-looking statements in this press release are expressly qualified by such cautionary statements, risk, and uncertainties, and by reference to the underlying assumptions.
Phone: 702.602.THCC (8422)
Follow Brandon Romanek on Facebook and Twitter:
Twitter @BrandonRomanek
Follow THC Therapeutics on Facebook and Twitter:
Twitter @THCTherapeutics
Facebook @THCTherapies